Xiangyu Medical Co Ltd
SSE:688626

Watchlist Manager
Xiangyu Medical Co Ltd Logo
Xiangyu Medical Co Ltd
SSE:688626
Watchlist
Price: 29.7 CNY -4.65% Market Closed
Market Cap: 4.8B CNY
Have any thoughts about
Xiangyu Medical Co Ltd?
Write Note

Xiangyu Medical Co Ltd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Xiangyu Medical Co Ltd
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Xiangyu Medical Co Ltd
SSE:688626
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Deferred Income Tax
ÂĄ5.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Deferred Income Tax
ÂĄ221.9m
CAGR 3-Years
52%
CAGR 5-Years
44%
CAGR 10-Years
60%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Deferred Income Tax
ÂĄ860.8m
CAGR 3-Years
173%
CAGR 5-Years
68%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Deferred Income Tax
ÂĄ14.1m
CAGR 3-Years
196%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Deferred Income Tax
ÂĄ8.8m
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Xiangyu Medical Co Ltd
Glance View

Market Cap
4.7B CNY
Industry
Health Care

Xiangyu Medical Co., Ltd. engages in the development, procurement, production, and sale of rehabilitation medical equipment. The company is headquartered in Anyang, Henan and currently employs 1,727 full-time employees. The company went IPO on 2021-03-31. The firm is mainly engaged in the independent research and development, production and marketing of intelligent rehabilitation equipment in the rehabilitation fields such as pain, neurology, orthopedics, traditional Chinese medicine, postpartum field, postoperative field, cardiopulmonary field, and medical-care integration. The firm's main products are divided into three categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy. The firm mainly conducts business within the domestic market.

Intrinsic Value
47.32 CNY
Undervaluation 37%
Intrinsic Value
Price

See Also

Back to Top